• Our value proposition
    is simple

    We improve a doctor's ability to diagnose cancer
    and we lower the cost of diagnosis.

    SpectraScience offers a simplified yet highly effective way of diagnosing colorectal cancer early, when recovery rates are high. Our WavSTAT Optical Biopsy System® uses light to diagnose tissue health. In fact, our patented technology instantly detects if tissue is normal, pre-cancerous or cancerous without the need for a costly physical biopsy.

    According to the American Cancer Society, over 140,000 new cases of colorectal cancer are expected in the US this year alone. This dreaded disease is the second leading cause of cancer-related deaths in the US (after lung cancer), and the third most common cancer overall. Only 39% of colorectal cancers are detected at an early stage.

  • Lighting the way to improve
    your practice.


    The proprietary WavSTAT Optical Biopsy System assists the practicing gastroenterologist who uses a flexible endoscope to find polyps that may be cancerous. The capability to distinguish if the tissue is cancerous or not is made immediately, and complements your expertise. The physician uses laser-induced fluorescence and an optical fiber to transmit laser light via the flexible endoscope to the tissue. The auto-fluorescence from the tissue is then collected and returned to an optical detector for analysis. The result is then available with no waiting days for a pathology report.

    Simply stated, we work with you to create better outcomes for your patients.

  • Lighting the way for more
    than just colorectal cancer.


    SpectraScience will continue to expand its business in the coming years with future applications and light-based technologies employed on our WavSTAT platform. Our near-term target indications include esophageal cancer, bladder cancer and lung cancer. We also continue discussions with multiple potential partners to explore opportunities in other types of cancer diagnosis.

    Our goal is to offer a choice of the best optical technologies for optimal, definitive clinical detection and diagnosis.

Spectra Science News